Experimental Adjuvant Chemotherapy: An Overview
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 103)
By way of introduction, I will indicate in some detail what the key words in my assigned title mean to me.
KeywordsLymphoma Leukemia Adenocarcinoma Oncol Sarcoma
Unable to display preview. Download preview PDF.
- De Vita VT (1984) Opening comments: only if you believe in magic. In: Salmon SE, Jones SE (eds) Adjuvant therapy of cancer IV. Grune and Stratton, Orlanda, pp 3–16Google Scholar
- Griswold DP Jr (1972) Consideration of the subcutaneously implanted B16 malanoma as a screening model for potential anticancer agents. Cancer Chemother Rep 3: 315–324Google Scholar
- Griswold DP Jr (1975) The potential for murine tumor models in surgical adjuvant chemotherapy. Cancer Chemother Rep 5: 187–204Google Scholar
- Griswold DP Jr, Schabel FM Jr, Corbett TH, Dykes DJ (1981) Concepts for controlling drug-resistant tumor cells. In: Fidler IF, White RJ (eds) Design of models for testing cancer therapeutic agents. Van Nostrand Reinhold, New York, pp 215–224Google Scholar
- Skipper HE (to be published) Laboratory models: some historical perspective. Cancer Treat Rep (Special Symposium Issue: Laboratory models and clinical cancer)Google Scholar
- Skipper HE (1985) What phenomena are primarily responsible for cancers being classified as responsive, refractory or very refractory to chemotherapy? Southern Research Institute, Birmingham, pp 201–203 (Booklet 2)Google Scholar
- Skipper HE, Schabel FM Jr (1982) Quantitative and cytokinetic studies in experimental tumor systems. In: Holland JF, Frei E III (eds) Cancer medicine, 2nd edn. Lea and Febinger, Philadelphia, pp 663–685Google Scholar
- Skipper HE, Simpson-Herren L (1985) Relationship between tumor stem cell heterogeneity and responsiveness to chemotherapy. In: De Vita VT, Hellman J, Rosenberg SA (eds) Important advances in oncology 1985. Lippincott, Philadelphia, pp 63–77Google Scholar
© Springer-Verlag Berlin Heidelberg 1986